Ivermectin has topical anti-inflammatory properties

January 9, 2017

(HealthDay)—Ivermectin (IVM) has anti-inflammatory properties that could be beneficial in treatment of T-cell mediated skin inflammatory diseases, according to an experimental study published online Jan. 4 in Allergy.

Erwan Ventre, Ph.D., from the Université de Lyon in France, and colleagues examined the activity of IVM in a murine model of induced by repeated exposure to Dermatophagoides farinae and in cellular immunology assays.

The researchers found that topical IVM correlated with improvement in allergic inflammation, with reduction of the priming and activation of allergen-specific T cells and the production of . IVM had no major effect on dendritic cell functions in vivo and in vitro, but following polyclonal and antigen-specific stimulation, IVM did impair T-cell activation, proliferation, and cytokine production.

"Altogether, our results show that IVM is endowed with topical anti-inflammatory properties that could have important applications for the treatment of T-cell mediated skin inflammatory diseases," the authors write.

Several authors were employed by Galderma, which manufactures ivermectin and funded the study.

Explore further: New treatment for allergic response targets mast cells

More information: Full Text (subscription or payment may be required)

Related Stories

New treatment for allergic response targets mast cells

November 21, 2016

Researchers from North Carolina State University and the National Institutes of Health (NIH) have developed a method that stops allergic reactions by removing a key receptor from mast cells and basophils. Their work has implications ...

Beta-carotene, lycopene prevent dermatitis in murine model

March 24, 2016

(HealthDay)—Oral administration of β-carotene or lycopene prevents atopic dermatitis (AD)-like dermatitis in HR-1 hairless mice, according to an experimental study published online March 19 in the Journal of Dermatology.

Unique skin phenotype for pediatric atopic dermatitis

October 10, 2016

(HealthDay)—Pediatric patients with atopic dermatitis (AD) have a different skin phenotype from that of adult patients, according to a study published online Sept. 23 in the Journal of Allergy and Clinical Immunology.

Recommended for you

Every meal triggers inflammation

January 17, 2017

When we eat, we do not just take in nutrients – we also consume a significant quantity of bacteria. The body is faced with the challenge of simultaneously distributing the ingested glucose and fighting these bacteria. This ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.